378 related articles for article (PubMed ID: 12925966)
1. Changing epidemiology of malignant cutaneous melanoma in Europe 1953-1997: rising trends in incidence and mortality but recent stabilizations in western Europe and decreases in Scandinavia.
de Vries E; Bray FI; Coebergh JW; Parkin DM
Int J Cancer; 2003 Oct; 107(1):119-26. PubMed ID: 12925966
[TBL] [Abstract][Full Text] [Related]
2. Lower incidence rates but thicker melanomas in Eastern Europe before 1992: a comparison with Western Europe.
de Vries E; Boniol M; Doré JF; Coebergh JW;
Eur J Cancer; 2004 May; 40(7):1045-52. PubMed ID: 15093581
[TBL] [Abstract][Full Text] [Related]
3. Cutaneous melanoma.
Armstrong BK; Kricker A
Cancer Surv; 1994; 19-20():219-40. PubMed ID: 7534627
[TBL] [Abstract][Full Text] [Related]
4. International trends in the incidence of malignant melanoma 1953-2008--are recent generations at higher or lower risk?
Erdmann F; Lortet-Tieulent J; Schüz J; Zeeb H; Greinert R; Breitbart EW; Bray F
Int J Cancer; 2013 Jan; 132(2):385-400. PubMed ID: 22532371
[TBL] [Abstract][Full Text] [Related]
5. Trends in the survival of patients diagnosed with malignant melanoma of the skin in the Nordic countries 1964-2003 followed up to the end of 2006.
Tryggvadóttir L; Gislum M; Hakulinen T; Klint A; Engholm G; Storm HH; Bray F
Acta Oncol; 2010 Jun; 49(5):665-72. PubMed ID: 20491525
[TBL] [Abstract][Full Text] [Related]
6. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
7. The incidence and mortality of cutaneous melanoma in Southern Germany: trends by anatomic site and pathologic characteristics, 1976 to 2003.
Lasithiotakis KG; Leiter U; Gorkievicz R; Eigentler T; Breuninger H; Metzler G; Strobel W; Garbe C
Cancer; 2006 Sep; 107(6):1331-9. PubMed ID: 16909413
[TBL] [Abstract][Full Text] [Related]
8. Trends in incidence and predictions of cutaneous melanoma across Europe up to 2015.
Arnold M; Holterhues C; Hollestein LM; Coebergh JW; Nijsten T; Pukkala E; Holleczek B; Tryggvadóttir L; Comber H; Bento MJ; Diba ChS; Micallef R; Primic-Žakelj M; Izarzugaza MI; Perucha J; Marcos-Gragera R; Galceran J; Ardanaz E; Schaffar R; Pring A; de Vries E
J Eur Acad Dermatol Venereol; 2014 Sep; 28(9):1170-8. PubMed ID: 23962170
[TBL] [Abstract][Full Text] [Related]
9. The forthcoming inexorable decline of cutaneous melanoma mortality in light-skinned populations.
Autier P; Koechlin A; Boniol M
Eur J Cancer; 2015 May; 51(7):869-78. PubMed ID: 25771950
[TBL] [Abstract][Full Text] [Related]
10. Has mortality from malignant melanoma stopped rising in Spain? Analysis of trends between 1975 and 2001.
Cayuela A; Rodríguez-Domínguez S; Lapetra-Peralta J; Conejo-Mir JS
Br J Dermatol; 2005 May; 152(5):997-1000. PubMed ID: 15888159
[TBL] [Abstract][Full Text] [Related]
11. Cutaneous melanoma mortality starting to change: a study of trends in Northern Ireland.
Montella A; Gavin A; Middleton R; Autier P; Boniol M
Eur J Cancer; 2009 Sep; 45(13):2360-6. PubMed ID: 19375307
[TBL] [Abstract][Full Text] [Related]
12. Geographic and temporal variations in cancer of the corpus uteri: incidence and mortality in pre- and postmenopausal women in Europe.
Bray F; Loos AH; Oostindier M; Weiderpass E
Int J Cancer; 2005 Oct; 117(1):123-31. PubMed ID: 15880435
[TBL] [Abstract][Full Text] [Related]
13. Trends for in situ and invasive melanoma in Queensland, Australia, 1982-2002.
Coory M; Baade P; Aitken J; Smithers M; McLeod GR; Ring I
Cancer Causes Control; 2006 Feb; 17(1):21-7. PubMed ID: 16411049
[TBL] [Abstract][Full Text] [Related]
14. Malignant melanoma in the Czech Republic: incidence and mortality according to sex, age and disease stage.
Vranova J; Arenbergerova M; Arenberger P; Vrana A; Zivcak J; Kolarova H; Rosina J
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2014 Sep; 158(3):438-46. PubMed ID: 23128825
[TBL] [Abstract][Full Text] [Related]
15. Trends of liver cirrhosis mortality in Europe, 1970-1989: age-period-cohort analysis and changing alcohol consumption.
Corrao G; Ferrari P; Zambon A; Torchio P; Aricò S; Decarli A
Int J Epidemiol; 1997 Feb; 26(1):100-9. PubMed ID: 9126509
[TBL] [Abstract][Full Text] [Related]
16. Cutaneous malignant melanoma in Europe.
de Vries E; Coebergh JW
Eur J Cancer; 2004 Nov; 40(16):2355-66. PubMed ID: 15519506
[TBL] [Abstract][Full Text] [Related]
17. Effect of age, birth cohort and period of death on skin melanoma mortality in Spain, 1975 through 2004.
Cayuela A; Rodríguez-Domínguez S; Vigil E; Conejo-Mir JS
Int J Cancer; 2008 Feb; 122(4):905-8. PubMed ID: 17957799
[TBL] [Abstract][Full Text] [Related]
18. Development of prognostic factors and survival in cutaneous melanoma over 25 years: An analysis of the Central Malignant Melanoma Registry of the German Dermatological Society.
Buettner PG; Leiter U; Eigentler TK; Garbe C
Cancer; 2005 Feb; 103(3):616-24. PubMed ID: 15630700
[TBL] [Abstract][Full Text] [Related]
19. Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s.
Karim-Kos HE; de Vries E; Soerjomataram I; Lemmens V; Siesling S; Coebergh JW
Eur J Cancer; 2008 Jul; 44(10):1345-89. PubMed ID: 18280139
[TBL] [Abstract][Full Text] [Related]
20. Opportunistic screening strategy for cutaneous melanoma does not change the incidence of nodular and thick lesions nor reduce mortality: a population-based descriptive study in the European region with the highest incidence.
Bordoni A; Leoni-Parvex S; Peverelli S; Mazzola P; Mazzucchelli L; Spitale A
Melanoma Res; 2013 Oct; 23(5):402-7. PubMed ID: 23839077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
